UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)

Thrombosis research, 2018-02, Vol.162, p.88-92

2018

Volltextzugriff (PDF)

Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study

Journal of thrombosis and haemostasis, 2012-10, Vol.10 (10), p.2039-2044

2012

Volltextzugriff (PDF)

Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin

Circulation (New York, N.Y.), 2004-09, Vol.110 (12), p.1658-1663

2004

Volltextzugriff (PDF)

Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis

Journal of thrombosis and haemostasis, 2005-04, Vol.3 (4), p.718-723

2005

Volltextzugriff (PDF)

Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex

Kidney international, 2008-01, Vol.73 (2), p.213-219

2008

Volltextzugriff (PDF)

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1028-1035

2015

Volltextzugriff (PDF)

Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE

Thrombosis research, 2010-09, Vol.126 (3), p.222-226

2010

Volltextzugriff (PDF)

Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis

Journal of thrombosis and haemostasis, 2018-02, Vol.16 (2), p.262-270

2018

Volltextzugriff (PDF)

Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post‐thrombotic syndrome

Journal of thrombosis and haemostasis, 2015-03, Vol.13 (3), p.398-408

2015

Volltextzugriff (PDF)

Predictors of post‐thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency

Journal of thrombosis and haemostasis, 2013-03, Vol.11 (3), p.474-480

2013

Volltextzugriff (PDF)

Ambulatory management of pulmonary embolism: a pragmatic evaluation

Journal of thrombosis and haemostasis, 2010-11, Vol.8 (11), p.2406-2411

2010

Volltextzugriff (PDF)

A pilot study of central venous catheter survival in cancer patients using low‐molecular‐weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study)

Journal of thrombosis and haemostasis, 2007-08, Vol.5 (8), p.1650-1653

2007

Volltextzugriff (PDF)

Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode

Journal of thrombosis and haemostasis, 2017-10, Vol.15 (10), p.1977-1980

2017

Volltextzugriff (PDF)

Antepartum Dalteparin Versus no Antepartum Dalteparin for the Prevention of Pregnancy Complications in Pregnant Women With Thrombophilia (TIPPS): A Multinational Open-label Randomized Trial

Obstetric anesthesia digest, 2015-12, Vol.35 (4), p.206-207

2015

Volltextzugriff (PDF)

O4 Comorbidity, age and performance status are important predictors of outcome in older multiple myeloma patients treated with melphalan and corticosteroids: subgroup analysis from the National Cancer Institute of Canada MY7 trial

Critical reviews in oncology/hematology, 2009, Vol.72 (1), p.S15-S16

2009

Volltextzugriff (PDF)

Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients

Journal of thrombosis and haemostasis, 2013-01, Vol.11 (1), p.200-203

2013

Volltextzugriff (PDF)

Conservative perioperative anticoagulation management in patients with chronic venous thromboembolic disease: a cohort study

Journal of thrombosis and haemostasis, 2012-11, Vol.10 (11), p.2298-2304

2012

Volltextzugriff (PDF)

Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence

Journal of thrombosis and haemostasis, 2011-12, Vol.9 (12), p.2406-2410

2011

Volltextzugriff (PDF)

Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial

Journal of thrombosis and haemostasis, 2007-08, Vol.5 (8), p.1600-1606

2007

Volltextzugriff (PDF)

2 The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia: a randomized trial

Thrombosis research, 2007, Vol.119, p.S97-S97

2007

Volltextzugriff (PDF)

The management of a sub‐segmental pulmonary embolism: a cross‐sectional survey of Canadian thrombosis physicians

Journal of thrombosis and haemostasis, 2011-07, Vol.9 (7), p.1412-1415

2011

Volltextzugriff (PDF)

Comparison of the Villalta post‐thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis

Journal of thrombosis and haemostasis, 2012-06, Vol.10 (6), p.1036-1042

2012

Volltextzugriff (PDF)

Combined use of clinical assessment and d‐dimer to improve the management of patients presenting to the emergency department with suspected deep vein thrombosis (the EDITED Study)

Journal of thrombosis and haemostasis, 2003-04, Vol.1 (4), p.645-651

2003

Volltextzugriff (PDF)

Validation of a diagnostic approach to exclude recurrent venous thromboembolism

Journal of thrombosis and haemostasis, 2009-05, Vol.7 (5), p.752-759

2009

Volltextzugriff (PDF)

HYPERCHOLESTEROLEMIA IS STRONGLY ASSOCIATED WITH RISK OF RECURRENT VTE IN WOMEN TREATED FOR 5-7 MONTHS WITH ORAL ANTICOAGULANTS (OAC) FOR IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE)

Journal of thrombosis and haemostasis, 2007-07, Vol.5, p.P-W-444-P-W-444

2007

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(99)
Tagungsberichte
(2)

Sprache

Englisch
(100)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)

Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study

Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin

Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis

Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE

Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis

Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post‐thrombotic syndrome

Predictors of post‐thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency

Ambulatory management of pulmonary embolism: a pragmatic evaluation

A pilot study of central venous catheter survival in cancer patients using low‐molecular‐weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study)

Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode

Antepartum Dalteparin Versus no Antepartum Dalteparin for the Prevention of Pregnancy Complications in Pregnant Women With Thrombophilia (TIPPS): A Multinational Open-label Randomized Trial

O4 Comorbidity, age and performance status are important predictors of outcome in older multiple myeloma patients treated with melphalan and corticosteroids: subgroup analysis from the National Cancer Institute of Canada MY7 trial

Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients

Conservative perioperative anticoagulation management in patients with chronic venous thromboembolic disease: a cohort study

Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence

Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial

2 The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia: a randomized trial

The management of a sub‐segmental pulmonary embolism: a cross‐sectional survey of Canadian thrombosis physicians

Comparison of the Villalta post‐thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis

Combined use of clinical assessment and d‐dimer to improve the management of patients presenting to the emergency department with suspected deep vein thrombosis (the EDITED Study)

Validation of a diagnostic approach to exclude recurrent venous thromboembolism

HYPERCHOLESTEROLEMIA IS STRONGLY ASSOCIATED WITH RISK OF RECURRENT VTE IN WOMEN TREATED FOR 5-7 MONTHS WITH ORAL ANTICOAGULANTS (OAC) FOR IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE)

Suchergebnisse filtern